https://gpcardio.org/en/
https://gpcardio.org/en/2014-05-28_practical-guidance-for-primary-care-physicians-on-statin-use-in-people-at-risk-of-getting-diabetes/
https://gpcardio.org/en/2015-01-07_the-epccs-stroke-prevention-in-atrial-fibrillation-guidance-document-1/
https://gpcardio.org/en/2015-09-29_lively-debate-at-annual-epccs-clinical-masterclass-to-yield-practical-guidance/
https://gpcardio.org/en/2015-10-02_what-s-the-evidence-base-for-blood-pressure-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-02_what-s-the-evidence-base-for-health-behaviour-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-12_what-s-the-evidence-base-for-lipid-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-14_what-s-the-evidence-base-for-heart-failure-diagnosis-and-management-in-the-guideline-updates/
https://gpcardio.org/en/2016-03-15_what-is-the-evidence-base-for-lipid-modification-in-the-guidelines-updates/
https://gpcardio.org/en/2016-04-15_identifying-and-treating-patients-with-true-hypertension/
https://gpcardio.org/en/2016-05-26_the-evidence-base-for-health-behaviour-changes/
https://gpcardio.org/en/2016-09-06_epccs-consensus-guidance-on-stroke-prevention-in-atrial-fibrillation-spaf-in-primary-care/
https://gpcardio.org/en/2016-09-28_epccs-guidance-documents/
https://gpcardio.org/en/2017-03-30_guidance-on-changing-health-behaviours-what-is-the-evidence-what-s-recommended-and-do-i-agree/
https://gpcardio.org/en/2017-04-20_atrial-fibrillation-management-what-do-the-guidelines-say-and-what-are-the-implications-for-primary-care/
https://gpcardio.org/en/2017-04-20_controversies-in-hypertension-what-are-the-implication-of-sprint-in-the-context-of-recent-treatment-trials/
https://gpcardio.org/en/2017-04-20_controversies-in-lipids-is-the-role-of-statins-now-clear-are-there-alternatives-and-what-s-in-the-pipeline/
https://gpcardio.org/en/2017-04-20_guidance-on-changing-health-behaviours-what-is-the-evidence-what-s-recommended-and-do-i-agree/
https://gpcardio.org/en/2017-04-20_lipid-management-what-do-the-guidelines-say-and-what-are-the-implications-for-primary-care/
https://gpcardio.org/en/2017-04-20_what-s-the-new-evidence-base-for-heart-failure-diagnosis-management/
https://gpcardio.org/en/2017-06-05_ingredients-of-effective-strategies-to-stimulate-behaviour-change/
https://gpcardio.org/en/2017-06-22_how-do-the-latest-guideline-changes-affect-management-of-dyslipidaemia-in-primary-care/
https://gpcardio.org/en/2017-07-01_epccs-heart-failure-guidance-published-as-clinical-intelligence-in-br-j-gen-prac/
https://gpcardio.org/en/2017-07-18_heart-failure-diagnosis-and-management-varies-substantially-across-european-countries/
https://gpcardio.org/en/2017-09-13_what-can-be-learned-from-the-latest-hypertension-trials/
https://gpcardio.org/en/2017-12-10_epccs-practical-guidance-on-heart-failure-diagnosis-and-management-in-primary-care/
https://gpcardio.org/en/2018-02-06_how-can-epccs-expand-its-membership/
https://gpcardio.org/en/2018-02-06_how-can-the-epccs-better-engage-with-primary-care-physicians-in-various-european-countries-regarding-cardiovascular-disease-education/
https://gpcardio.org/en/2018-02-19_chronicke-srdcove-zlyhavanie/
https://gpcardio.org/en/2018-02-19_prevencia-cievnej-mozgovej-prihody-u-pacientov-s-fibrilaciou-predsieni/
https://gpcardio.org/en/2018-02-19_практична-настанова-по-діагностиці-та-менеджменту-серцевої-недостатності-в-системі-первинної-медичної-допомоги/
https://gpcardio.org/en/2018-02-22_stimulating-health-behaviour-changes-to-reduce-cardiovascular-risk-in-primary-care/
https://gpcardio.org/en/2018-02-25_slides-organisation-of-primary-care-in-the-netherlands/
https://gpcardio.org/en/2018-02-26_netherlands-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-26_slides-organisation-of-primary-care-in-slovakia/
https://gpcardio.org/en/2018-02-26_slides-primary-care-in-bulgaria-nagpb/
https://gpcardio.org/en/2018-02-26_slovakia-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-27_slides-cardiovascular-primary-care-in-spain/
https://gpcardio.org/en/2018-02-27_slides-organisation-of-primary-care-in-portugal/
https://gpcardio.org/en/2018-02-28_bulgaria-cardiovascular-primary-care/
https://gpcardio.org/en/2018-02-28_portugal-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-28_slides-cardiovascular-primary-care-in-france/
https://gpcardio.org/en/2018-02-28_spain-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_france-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_greece-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_romania-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_slides-cardiovascular-primary-care-in-greece/
https://gpcardio.org/en/2018-03-01_slides-cardiovascular-primary-care-in-romania/
https://gpcardio.org/en/2018-03-02_germany-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-02_slides-cardiovascular-primary-care-in-germany/
https://gpcardio.org/en/2018-03-13_погоджена-настанова-epccs-щодо-профілактики-інсульту-при-фібриляції-передсердь-в-системі-надання-первинної-медичної-допомоги/
https://gpcardio.org/en/2018-03-27_lower-extremity-artery-disease-a-neglected-major-cv-disease/
https://gpcardio.org/en/2018-03-27_stimularea-schimbarilor-de-comportament-in-domeniul-sanatatii-pentru-a-reduce-riscul-cardiovascular-in-asistenta-medicala-primara/
https://gpcardio.org/en/2018-03-28_diabetes-and-vascular-disease-epidemiology-and-management-options/
https://gpcardio.org/en/2018-04-04_managing-elevated-lipids-and-statins-the-good-the-bad-and-the-ugly/
https://gpcardio.org/en/2018-04-04_slides-hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-04-04_slides-lipid-lowering-the-evidence-the-guidelines-the-clinical-reality/
https://gpcardio.org/en/2018-04-04_slides-lower-extremity-artery-disease-a-neglected-major-cv-disease-diagnose-and-clinical-management-in-primary-care/
https://gpcardio.org/en/2018-04-04_slides-managing-complex-heart-failure-a-specialist-view-of-the-primary-secondary-interface/
https://gpcardio.org/en/2018-04-04_slides-managing-heart-failure-in-primary-care-the-gp-perspective/
https://gpcardio.org/en/2018-04-04_slides-practical-workshop-on-abpm/
https://gpcardio.org/en/2018-04-04_slides-type-2-diabetes-cardiovascular-disease-update/
https://gpcardio.org/en/2018-04-10_complexities-of-managing-heart-failure-in-primary-care/
https://gpcardio.org/en/2018-04-10_hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-04-24_management-of-cv-risk-that-comes-with-t2dm-in-light-of-novel-treatment-options/
https://gpcardio.org/en/2018-05-16_cardiovascular-primary-care-in-italy/
https://gpcardio.org/en/2018-05-16_slides-primary-care-in-italy/
https://gpcardio.org/en/2018-05-22_lipid-lowering-the-evidence-the-guidelines-the-clinical-reality/
https://gpcardio.org/en/2018-06-15_semergen-la-sociedad-decana-de-la-medicina-de-familia-en-espana/
https://gpcardio.org/en/2018-06-15_semergen-sociedad-espanola-de-medicos-de-atencion-primaria/
https://gpcardio.org/en/2018-06-19_spain-epccs-introduction/
https://gpcardio.org/en/2018-07-18_complexities-of-managing-heart-failure/
https://gpcardio.org/en/2018-08-16_hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-08-22_managing-elevated-lipids-in-primary-care/
https://gpcardio.org/en/2018-10-22_general-practitioner-in-denmark/
https://gpcardio.org/en/2018-10-22_managementul-dislipidemiei-in-asistenta-medicala-primara/
https://gpcardio.org/en/2018-10-22_praktican-vodic-za-dijagnostikovanje-i-lecenje-srcane-insuficijencije-u-primarnoj-zdravstvenoj-zastiti-pzz/
https://gpcardio.org/en/2018-10-22_stimulacija-promene-zivotnog-stila-u-cilju-smanjenja-kardiovaskularnog-rizika-u-pzz/
https://gpcardio.org/en/2018-10-23_prevention-of-cardiovascular-noncommunicable-disease-in-primary-care-in-russia/
https://gpcardio.org/en/2018-10-25_lecenje-povisenih-lipida-u-primarnoj-zdravstvenoj-zastiti-pzz/
https://gpcardio.org/en/2018-10-30_шляхи-стимулювання-модифікації-способу-життя-з-метою-зменшення-серцево-судинного-ризику-на-первинній-ланці-медичної-допомоги/
https://gpcardio.org/en/2018-12-03_primary-cardiovascular-care-in-serbia-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-czech-republic-czech/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-czech-republic-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-montenegro-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-serbia-serbian/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-ukraine-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-ukraine-ukrainian/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-belgium-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-belgium-flemish/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-poland-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-poland-polish/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-slovakia-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-slovakia-slovak/
https://gpcardio.org/en/2018-12-07_primary-cardiovascular-care-in-germany-english/
https://gpcardio.org/en/2018-12-07_primary-cardiovascular-care-in-germany-german/
https://gpcardio.org/en/2018-12-10_primary-cardiovascular-care-in-ireland-english/
https://gpcardio.org/en/2018-12-10_primary-cardiovascular-care-in-turkey-turkish/
https://gpcardio.org/en/2018-12-13_primary-cardiovascular-care-in-turkey-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-denmark-danish/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-denmark-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-montenegro-montenegrin/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-romania-romanian/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-spain-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-spain-spanish/
https://gpcardio.org/en/2018-12-18_slides-take-home-messages-of-epccs-guidance-on-managing-elevated-lipids-in-primary-care/
https://gpcardio.org/en/2019-01-10_primary-cardiovascular-care-in-spain-english/
https://gpcardio.org/en/2019-01-10_primary-cardiovascular-care-in-spain-spanish/
https://gpcardio.org/en/2019-02-07_epccs-society-what-is-available-for-members/
https://gpcardio.org/en/2019-02-25_current-management-of-diabetes-and-cardiovascular-risk-in-primary-care/
https://gpcardio.org/en/2019-03-28_diabetes-and-cardiovascular-risk/
https://gpcardio.org/en/2019-03-28_how-to-deal-with-the-challenges-of-multimorbidity-in-general-practice/
https://gpcardio.org/en/2019-03-28_update-on-stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-02_slides-complexities-of-managing-heart-failure/
https://gpcardio.org/en/2019-04-02_slides-cvd-and-mental-health/
https://gpcardio.org/en/2019-04-02_slides-diabetes-and-cardiovascular-risk/
https://gpcardio.org/en/2019-04-02_slides-multimorbidity-cv-disease-and-polypharmacy/
https://gpcardio.org/en/2019-04-02_slides-recent-updates-to-the-international-hypertension-guidelines-where-do-they-vary-and-what-should-we-agree-in-primary-care/
https://gpcardio.org/en/2019-04-02_slides-update-on-stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-02_slides-what-s-the-evidence-that-diabetes-is-linked-to-cvd-risk/
https://gpcardio.org/en/2019-04-03_complexities-of-managing-heart-failure/
https://gpcardio.org/en/2019-04-24_recent-updates-to-the-international-hypertension-guidelines-where-do-they-vary-and-what-should-we-agree-in-primary-care/
https://gpcardio.org/en/2019-04-25_education-exchange-guidance-and-interaction-during-epccs-summit-2019/
https://gpcardio.org/en/2019-05-02_slides-managing-diabetes-in-daily-cardiovascular-practice-a-multidisciplinary-approach/
https://gpcardio.org/en/2019-05-02_slides-targeting-cvd-in-diabetes-novel-strategies-to-tackle-the-risk/
https://gpcardio.org/en/2019-05-02_slides-type-2-diabetes-cv-outcomes-more-than-glucose-management-lessons-from-glp1-ra-trials/
https://gpcardio.org/en/2019-05-07_stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-05-21_update-on-managing-cv-risk-in-diabetes-what-s-the-evidence/
https://gpcardio.org/en/2019-06-18_new-diagnostic-algorithm-and-therapeutic-options-in-hf-management/
https://gpcardio.org/en/2019-08-13_slides-take-home-messages-of-epccs-guidance-on-current-management-of-diabetes-and-cv-risk-in-primary-care/
https://gpcardio.org/en/2019-08-29_diagnosis-and-management-of-hypertension-in-primary-care/
https://gpcardio.org/en/2019-10-02_outreach-of-epccs-into-european-countries-what-s-in-store/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-serbia/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-slovakia-english/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-slovakia-slovak/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-spain-english/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-spain-spanish/
https://gpcardio.org/en/2019-10-03_how-epccs-aims-to-help-primary-care-physicians-across-europe-in-recognizing-and-managing-cv-risk-greek/
https://gpcardio.org/en/2019-10-09_how-epccs-aims-to-help-primary-care-physicians-across-europe-in-recognizing-and-managing-cv-risk-english/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-french-abstract/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-greek-abstract/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-ukrainian-abstract/
https://gpcardio.org/en/2019-10-29_dijagnostikovanje-i-lecenje-hipertenzije-u-primarnoj-zdravstvenoj-zastiti-serbian-abstract-of-epccs-guidance-on-hypertension/
https://gpcardio.org/en/2019-10-29_french-society-of-general-medicine-sfmg/
https://gpcardio.org/en/2019-10-29_greek-societies-involved-in-primary-care/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-france/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-ireland/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-poland-english/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-poland-polish/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-turkey/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-ukraine/
https://gpcardio.org/en/2019-11-12_heart-failure-and-comorbidities-kidney-disease-and-cancer/
https://gpcardio.org/en/2022-06-02_need-to-restart-and-catch-up-in-cvd-prevention-in-time-of-covid-19/
https://gpcardio.org/en/2024-03-18_global-shift-from-underweight-to-obesity-dominance-in-three-decades-across-generations/
https://gpcardio.org/en/2024-04-02_stratify-hf-a-european-collaboration-to-develop-an-ai-based-support-system-for-risk-stratification-and-early-detection-of-heart-failure/
https://gpcardio.org/en/2024-04-07_gamification-and-financial-incentives-to-increase-physical-activity-among-patients-at-elevated-cv-risk/
https://gpcardio.org/en/2024-04-08_enhanced-remote-medication-program-boosts-gdmt-prescriptions-for-high-cv-or-kidney-risk-in-t2d-patients/
https://gpcardio.org/en/2024-04-08_web-app-effective-in-determining-access-to-statins-without-a-prescription/
https://gpcardio.org/en/2024-05-04_stratifyhf-providing-support-to-primary-care-in-early-diagnosis-of-heart-failure/
https://gpcardio.org/en/2024-05-06_the-stratifyhf-research-and-innovation-action/
https://gpcardio.org/en/2024-06-04_enhancing-cvd-risk-assessment-integrating-genetic-risk-for-improved-prediction/
https://gpcardio.org/en/2024-09-04_global-insights-from-the-interaspire-study-mapping-lipoprotein-a-prevalence-in-coronary-heart-disease-across-six-who-regions/
https://gpcardio.org/en/2024-12-14_the-vital-role-of-primary-care-in-advancing-cardiovascular-health/
https://gpcardio.org/en/2025-01-09_plozasiran-for-managing-persistent-chylomicronemia-and-pancreatitis-risk/
https://gpcardio.org/en/2025-01-09_transcatheter-valve-replacement-in-severe-tricuspid-regurgitation/
https://gpcardio.org/en/2025-01-14_transcatheter-edge-to-edge-repair-for-severe-isolated-tricuspid-regurgitation/
https://gpcardio.org/en/2025-01-21_early-intervention-in-patients-with-asymptomatic-severe-aortic-stenosis-and-myocardial-fibrosis/
https://gpcardio.org/en/2025-01-21_oral-muvalaplin-for-lowering-of-lipoprotein-a/
https://gpcardio.org/en/2025-01-23_abelacimab-versus-rivaroxaban-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2025-01-25_coronary-ct-angiography-guided-management-of-patients-with-stable-chest-pain/
https://gpcardio.org/en/2025-01-30_continuation-versus-interruption-of-oral-anticoagulation-during-tavi/
https://gpcardio.org/en/2025-01-30_tirzepatide-for-heart-failure-with-preserved-ejection-fraction-and-obesity/
https://gpcardio.org/en/2025-02-13_colchicine-in-acute-myocardial-infarction/
https://gpcardio.org/en/2025-02-13_routine-spironolactone-in-acute-myocardial-infarction/
https://gpcardio.org/en/2025-02-20_catheter-ablation-or-antiarrhythmic-drugs-for-ventricular-tachycardia/
https://gpcardio.org/en/2025-03-11_transcatheter-aortic-valve-replacement-in-patients-with-systolic-heart-failure-and-moderate-aortic-stenosis/
https://gpcardio.org/en/2025-03-15_study-on-cardiovascular-risk-factors-and-primary-care-utilization-in-spain/
https://gpcardio.org/en/2025-03-16_primary-prevention-of-atherosclerotic-cardiovascular-disease-ascvd-in-primary-care-a-systematic-review-of-guidelines/
https://gpcardio.org/en/2025-03-17_sex-differences-and-trends-in-cardiovascular-risk-management-insights-from-a-long-term-primary-care-study/
https://gpcardio.org/en/2025-03-27_intensive-blood-pressure-control-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2025-03-28_flecainide-acetate-inhalation-solution-for-cardioversion-of-recent-onset-symptomatic-atrial-fibrillation/
https://gpcardio.org/en/2025-04-03_left-atrial-appendage-closure-after-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2025-04-10_dapagliflozin-in-patients-undergoing-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2025-04-10_introducing-gpcardio-bridging-the-gap-in-cardiovascular-care/
https://gpcardio.org/en/2025-04-17_pulsed-field-or-cryoballoon-ablation-for-paroxysmal-atrial-fibrillation/
https://gpcardio.org/en/2025-05-08_lorundrostat-efficacy-and-safety-in-patients-with-uncontrolled-hypertension/
https://gpcardio.org/en/2025-05-17_fixed-dose-combination-of-obicetrapib-and-ezetimibe-for-ldl-cholesterol-reduction-tandem/
https://gpcardio.org/en/2025-05-29_oral-semaglutide-and-cardiovascular-outcomes-in-high-risk-type-2-diabetes/
https://gpcardio.org/en/2025-06-03_an-oral-pcsk9-inhibitor-for-treatment-of-hypercholesterolemia/
https://gpcardio.org/en/2025-06-10_2025-acc-aha-acep-naemsp-scai-guideline-for-the-management-of-patients-with-acute-coronary-syndromes/
https://gpcardio.org/en/2025-06-10_intravenous-ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2025-06-17_antihypertensive-medication-timing-and-cardiovascular-events-and-death/
https://gpcardio.org/en/2025-06-17_spironolactone-vs-amiloride-for-resistant-hypertension/
https://gpcardio.org/en/2025-07-01_add-on-treatment-with-zilebesiran-for-inadequately-controlled-hypertension/
https://gpcardio.org/en/2025-07-01_gpcardio-epccs-joins-each-in-european-alliance-for-cardiovascular-health/
https://gpcardio.org/en/2025-07-03_safety-and-efficacy-of-obicetrapib-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2025-07-07_colchicine-for-secondary-prevention-of-vascular-events/
https://gpcardio.org/en/2025-07-07_long-term-trials-of-colchicine-for-secondary-prevention-of-vascular-events/
https://gpcardio.org/en/2025-07-08_catheter-ablation-vs-lifestyle-modification-with-antiarrhythmic-drugs-to-treat-atrial-fibrillation/
https://gpcardio.org/en/2025-07-10_gpcardio-and-acc-s-ncd-academy-join-forces-to-strengthen-primary-care-in-cardiovascular-disease-prevention/
https://gpcardio.org/en/2025-07-12_amycretin-a-novel-unimolecular-glp-1-and-amylin-receptor-agonist-administered-subcutaneously/
https://gpcardio.org/en/2025-07-12_safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-the-first-in-class-glp-1-and-amylin-receptor-agonist-amycretin/
https://gpcardio.org/en/2025-07-15_10-year-outcome-of-complete-or-infarct-artery-only-revascularization-in-stemi-with-multivessel-disease/
https://gpcardio.org/en/2025-07-22_cooperative-pfa/
https://gpcardio.org/en/2025-07-28_long-term-benefits-of-atorvastatin-on-the-incidence-of-cardiovascular-events/
https://gpcardio.org/en/2025-07-29_cvd-primary-care-the-need-for-epccs-practice-guidance/
https://gpcardio.org/en/2025-08-05_lorundrostat-in-participants-with-uncontrolled-hypertension-and-treatment-resistant-hypertension/
https://gpcardio.org/en/2025-08-14_coadministered-cagrilintide-and-semaglutide-in-adults-with-overweight-or-obesity/
https://gpcardio.org/en/2025-08-21_preventive-percutaneous-coronary-intervention-for-non-flow-limiting-vulnerable-atherosclerotic-coronary-plaques-in-diabetes/
https://gpcardio.org/en/2025-08-30_blood-pressure-lowering-efficacy-of-antihypertensive-drugs-and-their-combinations/
https://gpcardio.org/en/2025-09-01_conduction-system-pacing-vs-biventricular-pacing-for-cardiac-resynchronization/
https://gpcardio.org/en/2025-09-02_remote-atrial-fibrillation-screening-in-primary-care-using-an-ecg-patch-demonstrates-modest-benefits/
https://gpcardio.org/en/2025-09-05_blood-pressure-reductions-with-baxdrostat-in-patients-with-uncontrolled-or-resistant-hypertension/
https://gpcardio.org/en/2025-09-11_multidomain-rehabilitation-for-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2025-09-11_new-guidance-recommends-a-new-approach-to-assess-cardiovascular-risk-and-reach-treatment-goals-for-lipid-levels/
https://gpcardio.org/en/2025-09-13_β-blockers-after-myocardial-infarction-with-mildly-reduced-ejection-fraction/
https://gpcardio.org/en/2025-09-16_2025-aha-acc-aanp-aapa-abc-accp-acpm-ags-ama-aspc-nma-pcna-sgim-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/en/2025-09-16_tackling-the-enduring-cardiovascular-impact-of-covid-19-new-guidance-for-primary-care/
https://gpcardio.org/en/2025-09-18_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-in-early-type-2-diabetes/
https://gpcardio.org/en/2025-09-20_effect-of-evolocumab-on-saphenous-vein-graft-patency-after-coronary-artery-bypass-surgery-newton-cabg-cardiolink-5/
https://gpcardio.org/en/2025-09-21_introduction-and-the-impact-of-cmr-on-patients-and-health-systems/
https://gpcardio.org/en/2025-09-24_key-changes-in-clinical-guidance-for-blood-pressure-and-lipid-management/
https://gpcardio.org/en/2025-09-25_digitoxin-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2025-09-28_why-it-s-important-to-recognise-manage-chronic-kidney-disease-ckd/
https://gpcardio.org/en/2025-10-01_no-evidence-supports-vitamins-or-supplements-for-lowering-ldl-cholesterol-and-reducing-cardiovascular-risk/
https://gpcardio.org/en/2025-10-07_impact-of-obicetrapib-on-major-adverse-cardiovascular-events-in-high-risk-patients/
https://gpcardio.org/en/2025-10-09_efficacy-and-safety-of-baxdrostat-in-uncontrolled-and-resistant-hypertension/
https://gpcardio.org/en/2025-10-14_long-term-anticoagulation-discontinuation-after-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2025-10-27_bridging-heart-and-stroke-awareness-stronger-together/
https://gpcardio.org/en/2025-10-28_effect-of-intensive-blood-pressure-control-on-stroke/
https://gpcardio.org/en/2025-10-28_immediate-or-deferred-nonculprit-lesion-pci-in-myocardial-infarction/
https://gpcardio.org/en/2025-10-28_intensive-blood-pressure-control-in-older-patients-with-hypertension/
https://gpcardio.org/en/2025-11-04_2025-aha-acc-aanp-aapa-abc-accp-acpm-ags-ama-aspc-nma-pcna-sgim-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/en/2025-11-06_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-for-obesity-treatment/
https://gpcardio.org/en/2025-11-09_pcsk9-inhibitor-prevents-first-heart-attack-or-stroke-in-high-risk-patients/
https://gpcardio.org/en/2025-11-10_high-dose-vs-standard-dose-influenza-vaccine-and-cardiovascular-outcomes-in-older-adults/
https://gpcardio.org/en/2025-11-11_decaf-a-cup-of-coffee-a-day-could-keep-atrial-fibrillation-from-coming-back/
https://gpcardio.org/en/2025-11-13_beta-blockers-after-myocardial-infarction-in-patients-without-heart-failure/
https://gpcardio.org/en/2025-11-13_beta-blockers-after-myocardial-infarction-without-reduced-ejection-fraction/
https://gpcardio.org/en/2025-11-18_2025-acc-scientific-statement-on-the-management-of-obesity-in-adults-with-heart-failure/
https://gpcardio.org/en/2025-11-18_dapagliflozin-in-patients-hospitalized-for-heart-failure/
https://gpcardio.org/en/2025-11-21_epccs-council-launches-gpcardio-as-a-commitment-to-support-primary-care/
https://gpcardio.org/en/2025-12-13_complete-versus-culprit-lesion-only-revascularisation-for-acute-myocardial-infarction-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/en/2025-12-16_long-term-effect-of-icds-in-nonischemic-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2025-12-18_2025-acc-aha-hrs-isachd-scai-guideline-for-the-management-of-adults-with-congenital-heart-disease/
https://gpcardio.org/en/2025-12-18_improve-dice-a-2-part-open-label-phase-2a-trial-evaluating-the-safety-and-effectiveness-of-ninerafaxstat-in-patients-with-cardiometabolic-syndromes/
https://gpcardio.org/en/2025-12-19_eu-launches-ambitious-safe-hearts-plan-a-new-roadmap-in-cardiovascular-health/
https://gpcardio.org/en/2025-12-20_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-for-the-treatment-of-obesity-in-people-with-type-2-diabetes-attain-2/
https://gpcardio.org/en/2026-01-06_global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity-issued-by-who/
https://gpcardio.org/en/2026-01-07_cxcr6-t-cells-drive-immune-checkpoint-inhibitor-myocarditis/
https://gpcardio.org/en/2026-01-10_nicotine-and-the-cardiovascular-system-key-insights-for-primary-care/
https://gpcardio.org/en/2026-01-13_efficacy-and-safety-of-oral-pcsk9-inhibitor-enlicitide-in-adults-with-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2026-01-14_glucagon-like-receptor-agonists-and-next-generation-incretin-based-medications/
https://gpcardio.org/en/2026-01-15_socioeconomic-and-structural-barriers-to-addressing-obesity-in-communities/
https://gpcardio.org/en/2026-01-19_stroke-identified-as-the-second-leading-cause-of-death-from-cardiovascular-disease-and-a-major-contributor-of-acquired-long-term-disability/
https://gpcardio.org/en/2026-01-20_environmental-stressors-and-cardiovascular-health/
https://gpcardio.org/en/2026-01-20_sglt2-inhibitors-and-kidney-outcomes-by-glomerular-filtration-rate-and-albuminuria/
https://gpcardio.org/en/2026-01-20_triple-versus-dual-lipid-lowering-therapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2026-01-21_2026-heart-disease-and-stroke-statistics/
https://gpcardio.org/en/2026-01-22_antithrombotic-therapy-after-successful-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-01-27_colchicine-in-acute-coronary-syndromes/
https://gpcardio.org/en/2026-01-27_potent-p2y12-inhibitor-monotherapy-vs-dapt-after-pci-in-patients-with-and-without-stemi/
https://gpcardio.org/en/2026-01-29_olezarsen-for-managing-severe-hypertriglyceridemia-and-pancreatitis-risk/
https://gpcardio.org/en/2026-01-30_systemic-embolic-events-in-atrial-fibrillation/
https://gpcardio.org/en/2026-02-01_semaglutide-and-hospitalizations-in-patients-with-obesity-and-established-cardiovascular-disease/
https://gpcardio.org/en/2026-02-01_β-blockers-after-myocardial-infarction-in-patients-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-02-03_dapagliflozin-to-reduce-early-recurrence-after-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-02-04_ai-digital-stethoscopes-outperform-traditional-screening-for-significant-vhd/
https://gpcardio.org/en/2026-02-05_efimosfermin-alfa-bos-580-once-per-month-in-people-with-metabolic-dysfunction-associated-steatohepatitis-with-f2-or-f3-fibrosis/
https://gpcardio.org/en/2026-02-05_intravenous-tenecteplase-for-acute-ischaemic-stroke-within-24-h-due-to-basilar-artery-occlusion/
https://gpcardio.org/en/2026-02-05_tenecteplase-versus-standard-medical-treatment-for-basilar-artery-occlusion-within-24-h-trace-5/
https://gpcardio.org/en/2026-02-06_talking-to-patients-about-statins-why-most-reported-symptoms-aren-t-causal/
https://gpcardio.org/en/2026-02-09_coronary-atherosclerosis-in-patients-with-cancer-and-survivors/
https://gpcardio.org/en/2026-02-10_clonal-hematopoiesis-and-its-cardiovascular-implications/
https://gpcardio.org/en/2026-02-10_new-drug-therapies-for-hypertension/
https://gpcardio.org/en/2026-02-10_spontaneous-myocardial-infarction-after-left-main-revascularization/
https://gpcardio.org/en/2026-02-10_transthyretin-cardiac-amyloidosis-evaluation-and-management/
https://gpcardio.org/en/2026-02-11_criteria-to-assess-the-predictive-and-clinical-utility-of-novel-models-biomarkers-and-tools-for-risk-of-cardiovascular-disease/
https://gpcardio.org/en/2026-02-11_vericiguat-and-mortality-in-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2026-02-18_beta-blockers-after-myocardial-infarction/
https://gpcardio.org/en/2026-02-18_gene-therapy-for-nephropathic-cystinosis/
https://gpcardio.org/en/2026-02-19_2026-aha-acc-accp-acep-chest-scai-shm-sir-svm-svn-guideline-for-the-evaluation-and-management-of-acute-pulmonary-embolism-in-adults/
https://gpcardio.org/en/2026-02-19_conduction-disturbances-after-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2026-02-19_secondary-prevention-after-ischemic-stroke/
https://gpcardio.org/en/2026-02-19_transcatheter-or-surgical-aortic-valve-replacement-in-low-risk-patients-at-7-years/
https://gpcardio.org/en/2026-02-21_pelacarsen-and-lipoprotein-a-apheresis-in-secondary-prevention/
https://gpcardio.org/en/2026-02-23_immunoadsorption-in-dilated-cardiomyopathy/
https://gpcardio.org/en/2026-02-23_the-year-in-cardiovascular-medicine-2025/
https://gpcardio.org/en/2026-02-24_malnutrition-and-cachexia-in-inpatients-with-acute-cardiac-conditions/
https://gpcardio.org/en/2026-02-24_risk-of-heart-failure-hospitalization-for-glp-1-receptor-agonists-versus-dpp-4-inhibitors-or-sglt-2-inhibitors-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2026-02-25_combined-associations-of-glp-1-receptor-agonists-and-a-healthy-lifestyle-with-cardiovascular-outcomes-among-individuals-with-type-2-diabetes/
https://gpcardio.org/en/2026-02-25_forecasting-the-burden-of-cardiovascular-disease-and-stroke-in-women-in-the-united-states-through-2050/
https://gpcardio.org/en/2026-02-25_outcomes-of-heart-failure-with-reduced-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2026-02-27_carotid-plaque-macrophage-burden-and-inflammatory-lipid-associated-macrophage-markers-predict-secondary-major-adverse-cardiovascular-events-after-endarterectomy/
https://gpcardio.org/en/2026-02-27_sglt2-inhibition-in-patients-with-type-2-diabetes-and-ckd-experiencing-a-deterioration-in-estimated-glomerular-filtration-rate-to-20ml-min-1-73m/
https://gpcardio.org/en/2026-02-27_switching-from-warfarin-to-direct-oral-anticoagulants-in-frail-elderly-asian-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2026-02-28_heart-failure-in-the-elderly/
https://gpcardio.org/en/2026-03-02_nighttime-road-traffic-noise-stresses-the-heart-and-blood-vessels/
https://gpcardio.org/en/2026-03-04_aspirin-after-pci-in-acute-coronary-syndromes/
https://gpcardio.org/en/2026-03-04_blood-pressure-targets-in-hypertension-management/
https://gpcardio.org/en/2026-03-05_finerenone-in-type-1-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2026-03-05_oral-pcsk9-inhibitor-enlicitide-lowers-ldl-cholesterol-levels-in-phase-2-trial/
https://gpcardio.org/en/2026-03-06_kidney-disease-and-heart-failure/
https://gpcardio.org/en/2026-03-07_atrial-fibrillation/
https://gpcardio.org/en/2026-03-07_effect-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-bax24/
https://gpcardio.org/en/2026-03-07_effect-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-bax24/
https://gpcardio.org/en/2026-03-09_targets-and-treatments-to-manage-ldl-c-in-primary-care/
https://gpcardio.org/en/2026-03-10_genetic-screening-for-fh-rationale-and-experience/
https://gpcardio.org/en/2026-03-10_lp-a-time-to-start-measuring-in-primary-care/
https://gpcardio.org/en/2026-03-11_triglycerides-a-risk-marker-or-target-for-cv-risk/
https://gpcardio.org/en/2026-03-12_cardiovascular-metabolic-risk-in-menopause/
https://gpcardio.org/en/2026-03-12_esc-guidance-on-cvd-and-mental-health-in-primary-care/
https://gpcardio.org/en/2026-03-13_2026-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-dyslipidemia/
https://gpcardio.org/en/2026-03-13_heart-failure-in-primary-care-early-recognition-and-initiation-of-gdmt/
https://gpcardio.org/en/2026-03-13_managing-difficult-to-control-hypertension-and-what-s-new/
https://gpcardio.org/en/2026-03-13_the-need-for-gp-engagement-in-the-world-of-advocacy/
https://gpcardio.org/en/2026-03-14_the-pulse-of-primary-care-epccs-summit-2026/
https://gpcardio.org/en/2026-03-16_use-of-coronary-artery-calcium-scoring-in-individuals-with-elevated-lipoprotein-a/
https://gpcardio.org/en/2026-03-20_the-impact-of-epccs-guidance-on-pharmacotherapy-in-ukraine/
https://gpcardio.org/en/2026-03-22_cardiovascular-risk-management-in-poland/
https://gpcardio.org/en/2026-03-22_hypertension-guidelines-update-in-turkey/
https://gpcardio.org/en/2026-03-22_screening-for-cvd-in-greece/
https://gpcardio.org/en/2026-03-23_guideline-directed-medical-therapy-in-ckd-the-crucial-role-for-primary-care/
https://gpcardio.org/en/2026-03-24_managing-ckd-in-primary-care/
https://gpcardio.org/en/2026-03-24_screening-risk-stratification-in-ckd-the-crucial-role-for-primary-care/
https://gpcardio.org/en/2026-03-24_systemic-inflammation-and-recurrence-after-atrial-fibrillation-related-stroke/
https://gpcardio.org/en/about-epccs/
https://gpcardio.org/en/about-ipccs/
https://gpcardio.org/en/cvd-ckd-t2d/
https://gpcardio.org/en/each/
https://gpcardio.org/en/education/
https://gpcardio.org/en/education/cardio-renal-update/
https://gpcardio.org/en/education/cardiovascular-disease-in-special-populations/
https://gpcardio.org/en/education/cardiovascular-update-session-for-primary-care/
https://gpcardio.org/en/education/lipid-management-in-primary-care/
https://gpcardio.org/en/education/managing-cv-risk-in-europe-lessons-from-countries/
https://gpcardio.org/en/education/the-eu-cardiovascular-health-plan/
https://gpcardio.org/en/epccs/
https://gpcardio.org/en/epccs/connected-societies/
https://gpcardio.org/en/esc-congress-2025/
https://gpcardio.org/en/gpcardio/
https://gpcardio.org/en/literature/
https://gpcardio.org/en/ncd-academy/
https://gpcardio.org/en/resources/
https://gpcardio.org/en/resources/meeting-reports/
https://gpcardio.org/en/resources/practice-guidance/
https://gpcardio.org/en/resources/recent-news/
https://gpcardio.org/en/resources/stratifyhf/
https://gpcardio.org/en/resources/video-updates/
https://gpcardio.org/en/scan/
https://gpcardio.org/en/science-updates/
https://gpcardio.org/en/society-updates/
https://gpcardio.org/en/wonca-world-2025/